Literature DB >> 25851998

A germline MTOR mutation in Aboriginal Australian siblings with intellectual disability, dysmorphism, macrocephaly, and small thoraces.

Gareth Baynam1,2,3,4,5, Angela Overkov1, Mark Davis6,7, Kym Mina6,7, Lyn Schofield1,4, Richard Allcock6,7, Nigel Laing8, Matthew Cook9,10, Hugh Dawkins2,6,11,12, Jack Goldblatt1,2,3.   

Abstract

We report on three Aboriginal Australian siblings with a unique phenotype which overlaps with known megalencephaly syndromes and RASopathies, including Costello syndrome. A gain-of-function mutation in MTOR was identified and represents the first reported human condition due to a germline, familial MTOR mutation. We describe the findings in this family to highlight that (i) the path to determination of pathogenicity was confounded by the lack of genomic reference data for Australian Aboriginals and that (ii) the disease biology, functional analyses in this family, and studies on the tuberous sclerosis complex support consideration of an mTOR inhibitor as a therapeutic agent.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Aboriginal; RASopathy; indigenous; mTOR; megalencephaly; rapamycin; repurposing

Mesh:

Substances:

Year:  2015        PMID: 25851998     DOI: 10.1002/ajmg.a.37070

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus.

Authors:  Sheng Chih Jin; Weilai Dong; Adam J Kundishora; Shreyas Panchagnula; Andres Moreno-De-Luca; Charuta G Furey; August A Allocco; Rebecca L Walker; Carol Nelson-Williams; Hannah Smith; Ashley Dunbar; Sierra Conine; Qiongshi Lu; Xue Zeng; Michael C Sierant; James R Knight; William Sullivan; Phan Q Duy; Tyrone DeSpenza; Benjamin C Reeves; Jason K Karimy; Arnaud Marlier; Christopher Castaldi; Irina R Tikhonova; Boyang Li; Helena Perez Peña; James R Broach; Edith M Kabachelor; Peter Ssenyonga; Christine Hehnly; Li Ge; Boris Keren; Andrew T Timberlake; June Goto; Francesco T Mangano; James M Johnston; William E Butler; Benjamin C Warf; Edward R Smith; Steven J Schiff; David D Limbrick; Gregory Heuer; Eric M Jackson; Bermans J Iskandar; Shrikant Mane; Shozeb Haider; Bulent Guclu; Yasar Bayri; Yener Sahin; Charles C Duncan; Michael L J Apuzzo; Michael L DiLuna; Ellen J Hoffman; Nenad Sestan; Laura R Ment; Seth L Alper; Kaya Bilguvar; Daniel H Geschwind; Murat Günel; Richard P Lifton; Kristopher T Kahle
Journal:  Nat Med       Date:  2020-10-19       Impact factor: 53.440

2.  Divergent effects of intrinsically active MEK variants on developmental Ras signaling.

Authors:  Yogesh Goyal; Granton A Jindal; José L Pelliccia; Kei Yamaya; Eyan Yeung; Alan S Futran; Rebecca D Burdine; Trudi Schüpbach; Stanislav Y Shvartsman
Journal:  Nat Genet       Date:  2017-02-06       Impact factor: 38.330

Review 3.  Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.

Authors:  Kim M Keppler-Noreuil; Victoria E R Parker; Thomas N Darling; Julian A Martinez-Agosto
Journal:  Am J Med Genet C Semin Med Genet       Date:  2016-11-18       Impact factor: 3.908

4.  A Syndromic Intellectual Disability Disorder Caused by Variants in TELO2, a Gene Encoding a Component of the TTT Complex.

Authors:  Jing You; Nara L Sobreira; Dustin L Gable; Julie Jurgens; Dorothy K Grange; Newell Belnap; Ashley Siniard; Szabolcs Szelinger; Isabelle Schrauwen; Ryan F Richholt; Stephanie E Vallee; Mary Beth P Dinulos; David Valle; Mary Armanios; Julie Hoover-Fong
Journal:  Am J Hum Genet       Date:  2016-04-28       Impact factor: 11.025

5.  Equitable Expanded Carrier Screening Needs Indigenous Clinical and Population Genomic Data.

Authors:  Simon Easteal; Ruth M Arkell; Renzo F Balboa; Shayne A Bellingham; Alex D Brown; Tom Calma; Matthew C Cook; Megan Davis; Hugh J S Dawkins; Marcel E Dinger; Michael S Dobbie; Ashley Farlow; Kylie G Gwynne; Azure Hermes; Wendy E Hoy; Misty R Jenkins; Simon H Jiang; Warren Kaplan; Stephen Leslie; Bastien Llamas; Graham J Mann; Brendan J McMorran; Rebekah E McWhirter; Cliff J Meldrum; Shivashankar H Nagaraj; Saul J Newman; Jack S Nunn; Lyndon Ormond-Parker; Neil J Orr; Devashi Paliwal; Hardip R Patel; Glenn Pearson; Greg R Pratt; Boe Rambaldini; Lynette W Russell; Ravi Savarirayan; Matthew Silcocks; John C Skinner; Yassine Souilmi; Carola G Vinuesa; Gareth Baynam
Journal:  Am J Hum Genet       Date:  2020-08-06       Impact factor: 11.025

6.  Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy.

Authors:  Rikke S Møller; Sarah Weckhuysen; Mathilde Chipaux; Elise Marsan; Valerie Taly; E Martina Bebin; Susan M Hiatt; Jeremy W Prokop; Kevin M Bowling; Davide Mei; Valerio Conti; Pierre de la Grange; Sarah Ferrand-Sorbets; Georg Dorfmüller; Virginie Lambrecq; Line H G Larsen; Eric Leguern; Renzo Guerrini; Guido Rubboli; Gregory M Cooper; Stéphanie Baulac
Journal:  Neurol Genet       Date:  2016-10-31

7.  Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism.

Authors:  Kit San Yeung; Winnie Wan Yee Tso; Janice Jing Kun Ip; Christopher Chun Yu Mak; Gordon Ka Chun Leung; Mandy Ho Yin Tsang; Dingge Ying; Steven Lim Cho Pei; So Lun Lee; Wanling Yang; Brian Hon-Yin Chung
Journal:  Mol Autism       Date:  2017-12-20       Impact factor: 7.509

8.  Recessive Inactivating Mutations in TBCK, Encoding a Rab GTPase-Activating Protein, Cause Severe Infantile Syndromic Encephalopathy.

Authors:  Jessica X Chong; Viviana Caputo; Ian G Phelps; Lorenzo Stella; Lisa Worgan; Jennifer C Dempsey; Alina Nguyen; Vincenzo Leuzzi; Richard Webster; Antonio Pizzuti; Colby T Marvin; Gisele E Ishak; Simone Ardern-Holmes; Zara Richmond; Michael J Bamshad; Xilma R Ortiz-Gonzalez; Marco Tartaglia; Maya Chopra; Dan Doherty
Journal:  Am J Hum Genet       Date:  2016-03-31       Impact factor: 11.043

9.  Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities.

Authors:  Cameron Mroske; Kristen Rasmussen; Deepali N Shinde; Robert Huether; Zoe Powis; Hsiao-Mei Lu; Ruth M Baxter; Elizabeth McPherson; Sha Tang
Journal:  BMC Med Genet       Date:  2015-11-05       Impact factor: 2.103

10.  The rare and undiagnosed diseases diagnostic service - application of massively parallel sequencing in a state-wide clinical service.

Authors:  Gareth Baynam; Nicholas Pachter; Fiona McKenzie; Sharon Townshend; Jennie Slee; Cathy Kiraly-Borri; Anand Vasudevan; Anne Hawkins; Stephanie Broley; Lyn Schofield; Hedwig Verhoef; Caroline E Walker; Caron Molster; Jenefer M Blackwell; Sarra Jamieson; Dave Tang; Timo Lassmann; Kym Mina; John Beilby; Mark Davis; Nigel Laing; Lesley Murphy; Tarun Weeramanthri; Hugh Dawkins; Jack Goldblatt
Journal:  Orphanet J Rare Dis       Date:  2016-06-11       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.